Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Epinephrine vs Salbutamol in Bronchiolitis
NCT03814954Completed
- Sponsor
- Makassed General Hospital
- Start
- Jan 2019
- Primary completion
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of epinephrine in bronchiolitis (2 arms), sponsored by Makassed General Hospital. Primary endpoint: Length of stay at 5 days. Started Jan 2019; status: completed.
02
Drugs
epinephrine
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT03814954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814954.